Elevated plasma VEGF concentrations in preeclampsia are associated with local placental ischemia and endothelial dysfunction. We investigated the urinary VEGF excretion in women with severe preeclampsia (n=37) and its relation with proteinuria compared to that in healthy pregnant (n=32) and non-pregnant women (n=30). In women with severe preeclampsia VEGF levels were 54.0 (19.9–192.4) ng/mmol creatinine, significantly (p<0.0001) higher than levels in pregnant controls (28.2 (6.7–63.0) ng/mmol creatinine) and non-pregnant controls (29.5 (10.1–59.1) ng/mmol creatinine). Proteinuria was not significantly correlated with urinary VEGF levels. In conclusion, high urinary VEGF concentrations in severe preeclampsia might reflect increased renal production of VEGF rather than elevated VEGF levels in the systemic circulation.
JacksonM.R., CarneyE.W., LyeS.J., RitchieJ.W.. Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation.Placenta1994; 15: 341–53.
2.
BosioP.M., WheelerT., AnthonyF., ConroyR., O'HerlihyC., McKennaP.. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.Am J Obstet Gynecol2001; 184: 146–52.
3.
ShweikiD., ItinA., SofferD., KeshetE.. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.Nature1992; 359: 843–5.
4.
TsurumiY., MuroharaT., KrasinskiK.. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity.Nat Med1997; 3: 879–86.
BerseB., BrownL.F., Van de WaterL., DvorakH.F., SengerD.R.. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.Mol Biol Cell1992; 3: 211–20.
HonkanenE.O., TeppoA.M., Gronhagen-RiskaC.. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.Kidney Int2000; 57: 2343–9.
9.
AnthonyF.W., EvansP.W., WheelerT., WoodP.J.. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins.Ann Clin Biochem1997; 34: 276–80.
10.
JelkmannW.. Pitfalls in the measurement of circulating vascular endothelial growth factor.Clin Chem2001; 47: 617–23.
11.
SpanP.N., GrebenchtchikovN., Geurts-MoespotJ., WestphalJ.R., LucassenA.M., SweepC.G.. EORTC Receptor and Bio-marker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts.Int J Biol Markers2000; 15: 184–91.
12.
GrebenchtchikovN., SweepC.G., Geurts-MoespotA., PiffanelliA., FoekensJ.A., BenraadT.J.. An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood.J Immunol Methods2002; 268: 219–31.
13.
BrownL.F., BerseB., TognazziK.. Vascular permeability factor mRNA and protein expression in human kidney.Kidney Int1992; 42: 1457–61.
14.
GroneH.J., SimonM., GroneE.F.. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts.J Pathol1995; 177: 259–67.
15.
HaltiaA., SolinM.L., JalankoH., HolmbergC., MiettinenA., HolthoferH.. Mechanisms of proteinuria: vascular permeability factor in congenital nephrotic syndrome of the Finnish type.Pediatr Res1996; 40: 652–7.
16.
SheehanH.L.. Renal morphology in preeclampsia.Kidney Int1980; 18: 241–52.
17.
KitamotoY., MatsuoK., TomitaK.. Different response of urinary excretion of VEGF in patients with chronic and acute renal failure.Kidney Int2001; 59: 385–6.
18.
DvorakH.F.. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.J Clin Oncol2000; 20: 4368–80.
19.
MandersP., SweepF.C., Tjan-HeijnenV.C.. Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.Clin Cancer Res2003; 9: 6363–70.
20.
MandersP., BeexL.V., Tjan-HeijnenV.C., SpanP.N., SweepC.G.. Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma.Cancer2003; 98: 2125–32.
21.
JonesA., CrewJ.. Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression.Urol Clin North Am2000; 27: 191–7.
